TY - JOUR
T1 - Minnesota multiphasic personality inventory-2-restructured form (MMPI-2-RF) Normative Elevation Rates
T2 - Comparisons with Epidemiological Prevalence Rates
AU - Tarescavage, Anthony M.
AU - Marek, Ryan J.
AU - Finn, Jacob A.
AU - Hicks, Adam
AU - Rapier, Jessica L.
AU - Ben-Porath, Yossef S.
PY - 2013/10/1
Y1 - 2013/10/1
N2 - Odland, Berthelson, Sharma, Martin, and Mittenberg (2013) caution that clinically elevated scale scores produced by members of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF; Ben-Porath & Tellegen, 2008/2011) normative sample raise concerns about the potential for false positive findings of psychopathology. However, the MMPI-2-RF normative sample is intended to represent the general population of the United States, 26.2% of which met criteria for a Diagnostic and Statistical Manual-IV (APA, 1994) disorder in a 12-month period (Kessler, Chiu, Demler, & Walters, 2005). In the current study we compare scale elevation rates in the MMPI-2-RF normative sample to prevalence rates of mental disorders primarily drawn from the National Comorbidity Study Replication (Kessler et al., 2005). Our objective was to evaluate MMPI-2-RF elevation rates in an epidemiological context. Results indicate that MMPI-2-RF scale elevation rates were generally consistent with epidemiological data when examined in the context of standard interpretation guidelines for the inventory. We also reiterate Ben-Porath and Tellegens (2008/2011) caution that MMPI-2-RF scale elevations alone are not sufficient to indicate the presence of psychiatric disorder. Rather they are best viewed as indications of the need to evaluate the individual for possible disorder(s). Implications of these results, limitations of this study, and future directions in research are discussed.
AB - Odland, Berthelson, Sharma, Martin, and Mittenberg (2013) caution that clinically elevated scale scores produced by members of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF; Ben-Porath & Tellegen, 2008/2011) normative sample raise concerns about the potential for false positive findings of psychopathology. However, the MMPI-2-RF normative sample is intended to represent the general population of the United States, 26.2% of which met criteria for a Diagnostic and Statistical Manual-IV (APA, 1994) disorder in a 12-month period (Kessler, Chiu, Demler, & Walters, 2005). In the current study we compare scale elevation rates in the MMPI-2-RF normative sample to prevalence rates of mental disorders primarily drawn from the National Comorbidity Study Replication (Kessler et al., 2005). Our objective was to evaluate MMPI-2-RF elevation rates in an epidemiological context. Results indicate that MMPI-2-RF scale elevation rates were generally consistent with epidemiological data when examined in the context of standard interpretation guidelines for the inventory. We also reiterate Ben-Porath and Tellegens (2008/2011) caution that MMPI-2-RF scale elevations alone are not sufficient to indicate the presence of psychiatric disorder. Rather they are best viewed as indications of the need to evaluate the individual for possible disorder(s). Implications of these results, limitations of this study, and future directions in research are discussed.
KW - Minnesota Multiphasic Personality Inventory-2-Restructured Form
KW - MMPI-2-RF
KW - National Comorbidity Study
KW - National Comorbidity Study Replication
KW - Restructured Clinical Scales
UR - http://www.scopus.com/inward/record.url?scp=84884670544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884670544&partnerID=8YFLogxK
U2 - 10.1080/13854046.2013.832386
DO - 10.1080/13854046.2013.832386
M3 - Article
C2 - 23957313
AN - SCOPUS:84884670544
SN - 1385-4046
VL - 27
SP - 1106
EP - 1120
JO - Clinical Neuropsychologist
JF - Clinical Neuropsychologist
IS - 7
ER -